|
1
|
Mahmood S, Bin Nelson E, Padniewski J and
Nasr R: Polymyalgia rheumatica: An updated review. Cleve Clin J
Med. 87:549–556. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Raheel S, Shbeeb I, Crowson CS and
Matteson EL: Epidemiology of polymyalgia rheumatica 2000-2014 and
examination of incidence and survival trends over 45 years: A
population-based study. Arthritis Care Res (Hoboken). 69:1282–1285.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
González-Gay MA, Matteson EL and Castañeda
S: Polymyalgia rheumatica. Lancet. 390:1700–1712. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Guggino G, Ferrante A, Macaluso F, Triolo
G and Ciccia F: Pathogenesis of polymyalgia rheumatica. Reumatismo.
70:10–17. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Salvarani C, Boiardi L, Mantovani V, Ranzi
A, Cantini F, Olivieri I, Bragliani M, Collina E and Macchioni PL:
HLA-DRB1 alleles associated with polymyalgia rheumatica in Northern
Italy: Correlation with disease severity. Ann Rheum Dis.
58:303–308. 1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
González-Gay MA, Amoli MM, Garcia-Porrua C
and Ollier WER: Genetic markers of disease susceptibility and
severity in giant cell arteritis and polymyalgia rheumatica. Semin
Arthritis Rheum. 33:38–48. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Carvajal Alegria G, Boukhlal S, Cornec D
and Devauchelle-Pensec V: The pathophysiology of polymyalgia
rheumatica, small pieces of a big puzzle. Autoimmun Rev.
19(102670)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Elling P, Olsson AT and Elling H:
Synchronous variations of the incidence of temporal arteritis and
polymyalgia rheumatica in different regions of Denmark; association
with epidemics of Mycoplasma pneumoniae infection. J Rheumatol.
23:112–119. 1996.PubMed/NCBI
|
|
9
|
Caruana G, Are R, Mastrandrea S, Fiore V,
Peruzzu F, Porqueddu E and Mura MS: Human Parvovirus B19 and
polymyalgia rheumatica: A case report and short review of the
literature. Infect Dis Trop Med. 1(e186)2015.
|
|
10
|
Uddhammar A, Boman J, Juto P and Rantapää
Dahlqvist S: Antibodies against Chlamydia pneumoniae,
cytomegalovirus, enteroviruses and respiratory syncytial virus in
patients with polymyalgia rheumatica. Clin Exp Rheumatol.
15:299–302. 1997.PubMed/NCBI
|
|
11
|
Cimmino MA and Zaccaria A: Epidemiology of
polymyalgia rheumatica. Clin Exp Rheumatol. 18 (4 Suppl 20):S9–S11.
2000.PubMed/NCBI
|
|
12
|
Manzo C, Isetta M, Natale M and Castagna
A: Identification and classification of polymyalgia rheumatica
(PMR) and PMR-like syndromes following immune checkpoint inhibitors
(ICIs) therapy: Discussion points and grey areas emerging from a
systematic review of published literature. Medicines (Basel).
7(68)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Samson M, Audia S, Fraszczak J, Trad M,
Ornetti P, Lakomy D, Ciudad M, Leguy V, Berthier S, Vinit J, et al:
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant
cell arteritis and polymyalgia rheumatica pathogenesis. Arthritis
Rheum. 64:3788–3798. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dejaco C, Duftner C, Klauser A and
Schirmer M: Altered T-cell subtypes in spondyloarthritis,
rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int.
30:297–303. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Toussirot É, Régent A, Devauchelle-Pensec
V, Saraux A and Puéchal X: Interleukin-6: A promising target for
the treatment of polymyalgia rheumatica or giant cell arteritis?
RMD Open. 2(e000305)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
van der Geest KSM, Abdulahad WH, Chalan P,
Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM,
Bos NA, et al: Disturbed B cell homeostasis in newly diagnosed
giant cell arteritis and polymyalgia rheumatica. Arthritis
Rheumatol. 66:1927–1938. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Alvarez-Rodríguez L, Lopez-Hoyos M, Mata
C, Marin MJ, Calvo-Alen J, Blanco R, Aurrecoechea E, Ruiz-Soto M
and Martínez-Taboada VM: Circulating cytokines in active
polymyalgia rheumatica. Ann Rheum Dis. 69:263–269. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kreiner F, Langberg H and Galbo H:
Increased muscle interstitial levels of inflammatory cytokines in
polymyalgia rheumatica. Arthritis Rheum. 62:3768–75.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang H, Watanabe R, Berry GJ, Tian L,
Goronzy JJ and Weyand CM: Inhibition of JAK-STAT signaling
suppresses pathogenic immune responses in medium and large vessel
vasculitis. Circulation. 137:1934–1948. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Weyand CM, Hicok KC, Hunder GG and Goronzy
JJ: Tissue cytokine patterns in patients with polymyalgia
rheumatica and giant cell arteritis. Ann Intern Med. 121:484–491.
1994.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kreiner F, Langberg H and Galbo H:
Increased muscle interstitial levels of inflammatory cytokines in
polymyalgia rheumatica. Arthritis Care Res (Hoboken). 62:3768–3775.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Buttgereit F, Dejaco C, Matteson EL and
Dasgupta B: Polymyalgia rheumatica and giant cell arteritis a
systematic review. JAMA. 315:2442–2458. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cutolo M, Montecucco CM, Cavagna L,
Caporali R, Capellino S, Montagna P, Fazzuoli L, Villaggio B,
Seriolo B and Sulli A: Serum Cytokines and steroidal hormones in
polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann
Rheum Dis. 65:1438–1443. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Floris A, Piga M, Cauli A, Salvarani C and
Mathieu A: Polymyalgia rheumatica: An autoinflammatory disorder?
RMD Open. 4(e000694)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ji J, Liu X, Sundquist K, Sundquist J and
Hemminki K: Cancer risk in patients hospitalized with polymyalgia
rheumatica and giant cell arteritis: A follow-up study in Sweden.
Rheumatology (Oxford). 49:1158–1163. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Emamifar A, Hess S, Ellingsen T, Due Kay
S, Christian Bang J, Gerke O, Syrak Hansen P, Ahangarani Farahani
Z, Petersen H, Marcussen N, et al: Prevalence of newly diagnosed
malignancies in patients with polymyalgia rheumatica and giant cell
arteritis, comparison of 18F-FDG PET/CT scan with chest X-ray and
abdominal ultrasound: Data from a 40 week prospective, exploratory,
Single Centre study. J Clin Med. 9(3940)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bobircă A, Bobircă F, Ancuta I, Florescu
A, Pădureanu V, Florescu DN, Pădureanu R, Florescu A and Mușetescu
AE: Rheumatic immune-related adverse Events-A consequence of immune
checkpoint inhibitor therapy. Biology (Basel).
10(561)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Salvarani C, Cantini F and Hunder GG:
Polymyalgia rheumatica and giant-cell arteritis. Lancet.
372:234–245. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Salvarani C, Pipitone N, Versari A and
Hunder GG: Clinical features of polymyalgia rheumatica and giant
cell arteritis. Nat Rev Rheumatol. 8:509–521. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Prior JA, Muller S, Helliwell T, Hider SL,
Barraclough K, Dasgupta B and Mallen CD: The association of pain
and stiffness with fatigue in incident polymyalgia rheumatica:
Baseline results from the polymyalgia rheumatica cohort study. Prim
Health Care Res Dev. 20(e46)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gazitt T, Zisman D and Gardner G:
Polymyalgia rheumatica: A common disease in seniors. Curr Rheumatol
Rep. 22(40)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Clinical Manifestations and Diagnosis of
Polymyalgia Rheumatica-UpToDate Available online: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-polymyalgia-rheumatica
(Accessed on 19 August 2022).
|
|
33
|
Iagnocco A, Finucci A, Ceccarelli F,
Scirocco C and Rutigliano IM: Musculoskeletal ultrasound in the
evaluation of Polymyalgia Rheumatica. Med Ultrason. 17:361–366.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Manzo C and Natale M: Polymyalgia
rheumatica in association with remitting Seronegative Sinovitis
with pitting edema: A Neoplastic Warning. Can Geriatr J. 20:94–96.
2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kermani TA and Warrington KJ: Polymyalgia
rheumatica. Lancet. 381:63–72. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
González-Gay MA, Rodríguez-Valverde V and
Blanco R: Polymyalgia rheumatica without significantly increased
erythrocyte sedimentation rate: A more benign syndrome. Arch Intern
Med. 157:317–320. 1997.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cantini F, Salvarani C, Olivieri I,
Macchioni L, Ranzi A, Niccoli L, Padula A and Boiardi L:
Erythrocyte sedimentation rate and C-Reactive protein in the
evaluation of disease activity and severity in polymyalgia
rheumatica: A prospective follow-up study. Semin Arthritis Rheum.
30:17–24. 2000.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Salvarani C, Cantini F, Niccoli L,
Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG,
Pulsatelli L, Meliconi R, et al: Acute-phase reactants and the risk
of relapse/recurrence in polymyalgia rheumatica: A prospective
Follow-up study. Arthritis Rheum. 53:33–38. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Cutolo M, Cimmino MA and Sulli A:
Polymyalgia rheumatica vs Late-onset rheumatoid arthritis.
Rheumatology. 48:93–95. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Espinoza LR, Jara LJ, Silveira LH,
Martínez-Osuna P, Zwolinska JB, Kneer C and Aguilar JL:
Anticardiolipin antibodies in polymyalgia rheumaticagiant cell
arteritis: Association with severe vascular complications. Am J
Med. 90:474–478. 1991.PubMed/NCBI
|
|
41
|
Uddhammar AC: Von Willebrand factor in
polymyalgia rheumatica and giant cell arteritis. Clin Exp
Rheumatol. 18 (4 Suppl 20):S32–S33. 2000.PubMed/NCBI
|
|
42
|
Henderson DRF, Tribe CR and Dixon ASTJ:
Synovitis in polymyalgia rheumatica. Rheumatology. 14:244–250.
1975.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gherghina FL, Tica AA, Deliu E, Abood ME,
Brailoiu GC and Brailoiu E: Effects of VPAC1 activation in nucleus
ambiguus neurons. Brain Res. 1657:297–303. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Pulsatelli L, Dolzani P, Silvestri T, De
Giorgio R, Salvarani C, Macchioni P, Frizziero L and Meliconi R:
Synovial expression of vasoactive intestinal peptide in polymyalgia
rheumatica. Clin Exp Rheumatol. 24:562–566. 2006.PubMed/NCBI
|
|
45
|
Dasgupta B, Borg FA, Hassan N, Barraclough
K, Bourke B, Fulcher J, Hollywood J, Hutchings A, Kyle V, Nott J,
et al: BSR and BHPR guidelines for the management of polymyalgia
rheumatica. Rheumatology. 49:186–190. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Friedmann R, Feldman H and Nesher G:
Gallium-67 Scintigraphy in polymyalgia rheumatica. Clin Exp
Rheumatol. 25 (Suppl):S34–S35. 2007.PubMed/NCBI
|
|
47
|
O'Duffy JD, Wahner HW and Hunder GG: Joint
imaging in polymyalgia rheumatica. Mayo Clin Proc. 51:519–524.
1976.PubMed/NCBI
|
|
48
|
Jiménez-Palop M, Naredo E, Humbrado L,
Medina J, Uson J, Francisco F, García-Yebenes MJ and Garrido J:
Ultrasonographic monitoring of response to therapy in polymyalgia
rheumatica. Ann Rheum Dis. 69:879–882. 2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ruta S, Rosa J, Navarta DA, Saucedo C,
Catoggio LJ, Monaco RG and Soriano ER: Ultrasound assessment of new
onset bilateral painful shoulder in patients with polymyalgia
rheumatica and rheumatoid arthritis. Clin Rheumatol. 31:1383–1387.
2012.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Cantini F, Niccoli L, Nannini C, Padula A,
Olivieri I, Boiardi L and Salvarani C: Inflammatory changes of hip
synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol.
23:462–468. 2005.PubMed/NCBI
|
|
51
|
Dasgupta B, Cimmino MA, Kremers HM,
Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C,
Jensen HS, et al: 2012 provisional classification criteria for
polymyalgia rheumatica: A European league against
Rheumatism/American College of Rheumatology Collaborative
Initiative. Arthritis Rheum. 64:943–954. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Macchioni P, Boiardi L, Catanoso M,
Pazzola G and Salvarani C: Performance of the New 2012 EULAR/ACR
classification criteria for polymyalgia rheumatica: Comparison with
the previous criteria in a Single-Centre study. Ann Rheum Dis.
73:1190–1193. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kobayashi K, Nakagomi D, Kobayashi Y,
Ajima C, Hanai S, Koyama K and Ikeda K: Ultrasound of shoulder and
knee improves the accuracy of the 2012 EULAR/ACR provisional
classification criteria for polymyalgia rheumatica. Rheumatology
(Oxford). 61:1185–1194. 2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Mackie SL, Koduri G, Hill CL, Wakefield
RJ, Hutchings A, Loy C, Dasgupta B and Wyatt JC: Accuracy of
musculoskeletal imaging for the diagnosis of polymyalgia
rheumatica: Systematic review. RMD Open. 13(e000100)2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Manzo C, Milchert M, Isetta M, Natale M
and Castagna A: Early diagnosis in patients with polymyalgia
rheumatica: Is a fast track clinic a viable solution? Comment on:
‘Fast track clinic for early diagnosis of polymyalgia rheumatica:
Impact on symptom duration and prednisolone initiation’ by Frølund
et al. Joint Bone Spine 2021;88:105185. Joint Bone Spine.
88(105262)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Falsetti P, Acciai C, Volpe A and Lenzi L:
Ultrasonography in early assessment of elderly patients with
polymyalgic symptoms: A role in predicting diagnostic outcome?
Scand J Rheumatol. 40:57–63. 2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Suzuki T, Yoshida R, Hidaka Y and Seri Y:
Proliferative Synovitis of the Shoulder Bursae is a key feature for
discriminating elderly onset rheumatoid arthritis mimicking
polymyalgia rheumatica from polymyalgia rheumatica. Clin Med
Insights Arthritis Musculoskelet Disord.
10(179544117745851)2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Suzuki T, Yoshida R, Okamoto A and Seri Y:
Semiquantitative evaluation of extrasynovial soft tissue
inflammation in the shoulders of patients with polymyalgia
rheumatica and elderly-onset rheumatoid arthritis by power Doppler
ultrasound. Biomed Res Int. 2017(4272560)2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ottaviani S, Goossens J, Demaria L, Forien
M, Palazzo E and Dieudé P: Ultrasound shoulder assessment of
calcium pyrophosphate disease with suspected polymyalgia
rheumatica. Clin Exp Rheumatol. 38:1170–1175. 2020.PubMed/NCBI
|
|
60
|
Miceli MC, Zoli A, Peluso G, Bosello S,
Gremese E and Ferraccioli G: Baseline shoulder ultrasonography is
not a predictive marker of response to glucocorticoids in patients
with polymyalgia rheumatica: A 12-month followup study. J
Rheumatol. 44:241–247. 2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Huwart A, Garrigues F, Jousse-Joulin S,
Marhadour T, Guellec D, Cornec D, Gouillou M, Saraux A and
Devauchelle-Pensec V: Ultrasonography and magnetic resonance
imaging changes in patients with polymyalgia rheumatica treated by
tocilizumab. Arthritis Res Ther. 20(11)2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Fruth M, Buehring B, Baraliakos X and
Braun J: Use of Contrast-enhanced magnetic resonance imaging of the
pelvis to describe changes at different anatomic sites which are
potentially specific for polymyalgia rheumatica. Clin Exp
Rheumatol. 36 (Suppl):S86–S95. 2018.PubMed/NCBI
|
|
63
|
Fruth M, Seggewiss A, Kozik J,
Martin-Seidel P, Baraliakos X and Braun J: Diagnostic capability of
Contrast-Enhanced pelvic girdle magnetic resonance imaging in
polymyalgia rheumatica. Rheumatology (Oxford). 59:2864–2871.
2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Salvarani C, Barozzi L, Boiardi L,
Pipitone N, Bajocchi GL, Macchioni PL, Catanoso M, Pazzola G,
Valentino M, De Luca C and Hunder GG: Lumbar interspinous bursitis
in active polymyalgia rheumatica. Clin Exp Rheumatol. 31:526–531.
2013.PubMed/NCBI
|
|
65
|
Mackie SL, Pease CT, Fukuba E, Harris E,
Emery P, Hodgson R, Freeston J and McGonagle D: Whole-body MRI of
patients with polymyalgia rheumatica identifies a distinct subset
with complete patient-reported response to glucocorticoids. Ann
Rheum Dis. 74:2188–2192. 2015.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Cimmino MA, Parodi M, Zampogna G, Barbieri
F and Garlaschi G: Polymyalgia Rheumatica is associated with
extensor tendon tenosynovitis but not with synovitis of the hands:
A magnetic resonance imaging study. Rheumatology (Oxford).
50:494–499. 2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Ochi J, Nozaki T, Okada M, Suyama Y,
Kishimoto M, Akaike G, Tasaki A, Ohde S, Saida Y and Yoshioka H:
MRI findings of the shoulder and hip joint in patients with
polymyalgia rheumatica. Mod Rheumatol. 25:761–767. 2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Nakamura H, Kamada K, Tarumi M, Tanimura
S, Shibata Y and Horita T: Gadolinium-enhanced magnetic resonance
imaging in shoulders contributes accurate diagnosis and predicting
recurrence to patients with polymyalgia rheumatica. Clin Exp
Rheumatol. 39:84–90. 2021.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Laporte JP, Garrigues F, Huwart A,
Jousse-Joulin S, Marhadour T, Guellec D, Cornec D,
Devauchelle-Pensec V and Saraux A: Localized Myofascial
inflammation revealed by magnetic resonance imaging in recent-onset
polymyalgia rheumatica and effect of tocilizumab therapy. J
Rheumatol. 46:1619–1626. 2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Camellino D, Duftner C and Dejaco C: New
insights into the role of imaging in polymyalgia rheumatica.
Rheumatology (Oxford). 60:1016–1033. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Slart RHJA: Writing group; Reviewer group;
Members of EANM Cardiovascular; Members of EANM Infection &
Inflammation; Members of Committees, SNMMI Cardiovascular; Members
of Council, PET Interest Group; Members of ASNC and EANM Committee
Coordinator. FDG-PET/CT(A) imaging in large vessel Vasculitis and
polymyalgia rheumatica: Joint procedural recommendation of the
EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the
ASNC. Eur J Nucl Med Mol Imaging. 45:1250–1269. 2018.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Prieto-Peña D, Martínez-Rodríguez I,
Loricera J, Banzo I, Calderón-Goercke M, Calvo-Río V, González-Vela
C, Corrales A, Castañeda S, Blanco R, et al: Predictors of positive
18F-FDG PET/CT-scan for large vessel vasculitis in
patients with persistent polymyalgia rheumatica. Semin Arthritis
Rheum. 48:720–727. 2019.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Yuge S, Nakatani K, Yoshino K and Koyama
T: Diagnosing polymyalgia rheumatica on 18F-FDG PET/CT:
Typical uptake patterns. Ann Nucl Med. 32:573–577. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
van der Geest KSM, Treglia G, Glaudemans
AWJM, Brouwer E, Jamar F, Slart RHJA and Gheysens O: Diagnostic
Value of [18F]FDG-PET/CT in polymyalgia rheumatica: A
systematic review and meta-analysis. Eur J Nucl Med Mol Imaging.
48:1876–1889. 2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Kaneko K, Suematsu E, Miyamura T and
Ishioka H: Differences of Articular and Extra-articular involvement
in polymyalgia rheumatica: A comparison by whole-body FDG-PET/CT.
Mod Rheumatol. 30:358–364. 2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Rehak Z, Sprlakova-Pukova A, Kazda T,
Fojtik Z, Vargova L and Nemec P: 18F-FDG PET/CT in
polymyalgia rheumatica-a pictorial review. Br J Radiol.
90(20170198)2017.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Sondag M, Verhoeven F, Prati C, Guillot X,
Blagosklonov O, Boulahdour H and Wendling D: Involvement of Pubic
Symphysis in polymyalgia rheumatica: 18-FDG PET/CT Evaluation.
Joint Bone Spine. 84:635–636. 2017.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Takahashi H, Yamashita H, Kubota K, Miyata
Y, Okasaki M, Morooka M, Takahashi Y, Kaneko H, Kano T and Mimori
A: Differences in Fluorodeoxyglucose positron emission
Tomography/computed tomography findings between elderly onset
rheumatoid arthritis and polymyalgia rheumatica. Mod Rheumatol.
25:546–551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wendling D, Sondag M, Giraud N, Chouk M,
Boulahdour H, Prati C and Verhoeven F: Muscle involvement on
18F-FDG PET-CT in polymyalgia rheumatica. A controlled
retrospective study of 101 patients. Joint Bone Spine. 87:225–228.
2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Chuang TY, Hunder GG, Ilstrup DM and
Kurland LT: Polymyalgia rheumatica: A 10-year epidemiologic and
clinical study. Ann Intern Med. 97:672–679. 1982.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Healey LA: Long-Term Follow-up of
polymyalgia rheumatica: evidence for Synovitis. Semin Arthritis
Rheum. 13:322–328. 1984.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Jones JG and Hazleman BL: Prognosis and
management of polymyalgia rheumatica. Ann Rheum Dis. 40:1–5.
1981.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Bird HA, Esselinckx W, Dixon SAJ, Mowat AG
and Wood PH: An evaluation of criteria for polymyalgia rheumatica.
Ann Rheum Dis. 38:434–439. 1979.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Matteson EL and Dejaco C: Polymyalgia
rheumatica. Ann Intern Med. 166:ITC65–ITC80. 2017.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Nothnagl T and Leeb BF: Diagnosis,
differential diagnosis and treatment of polymyalgia rheumatica.
Drugs Aging. 23:391–402. 2006.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Nesher G: Polymyalgia rheumatica-diagnosis
and classification. J Autoimmun. 48-49:76–78. 2014.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Dejaco C, Duftner C, Cimmino MA, Dasgupta
B, Salvarani C, Crowson CS, Maradit-Kremers H, Hutchings A,
Matteson EL and Schirmer M: International Work Group for PMR and
GCA. Definition of remission and relapse in polymyalgia rheumatica:
Data from a literature search compared with a Delphi-Based expert
consensus. Ann Rheum Dis. 70:447–453. 2011.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Dejaco C, Singh YP, Perel P, Hutchings A,
Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K,
et al: 2015 Recommendations for the management of polymyalgia
rheumatica: A European league against Rheumatism/American College
of Rheumatology Collaborative Initiative. Ann Rheum Dis.
74:1799–1807. 2015.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Ruediger C, Nguyen L, Black R, Proudman S
and Hill C: Efficacy of methotrexate in polymyalgia rheumatica in
routine rheumatology clinical care. Intern Med J. 50:1067–1072.
2020.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Caporali R, Cimmino MA, Ferraccioli G,
Gerli R, Klersy C, Salvarani C and Montecucco C: Prednisone plus
methotrexate for polymyalgia rheumatica: A randomized,
Double-blind, Placebo-controlled trial. Ann Intern Med.
141:493–500. 2004.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Marsman DE, Bolhuis TE, den Broeder N, den
Broeder AA and van der Maas A: PolyMyalgia rheumatica treatment
with methotrexate in optimal dose in an early disease phase (PMR
MODE): Study protocol for a multicenter double-blind placebo
controlled trial. Trials. 23(318)2022.PubMed/NCBI View Article : Google Scholar
|
|
92
|
De Silva M and Hazleman BL: Azathioprine
in giant cell arteritis/polymyalgia rheumatica: A double-blind
study. Ann Rheum Dis. 45(136)1986.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Lee JH, Choi ST, Kim JS, Yoon BY, Kwok SK,
Kim HS, Kim YS, Song JS, Lee SH and Kim HR: Clinical
characteristics and prognostic factors for relapse in patients with
polymyalgia rheumatica (PMR). Rheumatol Int. 33:1475–1480.
2013.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Lally L, Forbess L, Hatzis C and Spiera R:
Brief report: A Prospective open-label phase IIa trial of
tocilizumab in the treatment of polymyalgia rheumatica. Arthritis
Rheumatol. 68:2550–2554. 2016.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Devauchelle-Pensec V, Berthelot JM, Cornec
D, Renaudineau Y, Marhadour T, Jousse-Joulin S, Querellou S,
Garrigues F, de Bandt M, Gouillou M and Saraux A: Efficacy of
First-line tocilizumab therapy in early polymyalgia rheumatica: A
prospective longitudinal study. Ann Rheum Dis.
75(1506)2016.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Antiochos B: Tocilizumab as a novel
therapy for steroid-dependent polymyalgia rheumatica. JAMA.
328:1047–1048. 2022.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Mori S and Koga Y:
Glucocorticoid-resistant polymyalgia rheumatica: Pretreatment
characteristics and tocilizumab therapy. Clin Rheumatol.
35(1367)2016.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Bonelli M, Radner H, Kerschbaumer A, Mrak
D, Durechova M, Stieger J, Husic R, Mandl P, Smolen JS, Dejaco C
and Aletaha D: Tocilizumab in patients with new onset polymyalgia
rheumatica (PMR-SPARE): A phase 2/3 randomised controlled trial.
Ann Rheum Dis. 81:838–844. 2022.PubMed/NCBI View Article : Google Scholar
|
|
99
|
A 2-Week Single-Blind, Randomized, 3-Arm
Proof of Concept Study of the Effects of Secukinumab (Anti-IL17
MAb), Canakinumab (Anti-IL-1 b MAb), or Corticosteroids on Initial
Disease Activity Scores in Patients with PMR, Followed By an
Open-Label Extension to Assess Safety and Effect Duration-ACR
Meeting Abstracts Available from: https://acrabstracts.org/abstract/a-2-week-single-blind-randomized-3-arm-proof-of-concept-study-of-the-effects-of-secukinumab-anti-il17-mab-canakinumab-anti-il-1-b-mab-or-corticosteroids-on-initial-disease-activity-scores-in-p/.
Accessed on 31 August 2022.
|
|
100
|
Koster MJ, Crowson CS, Giblon RE, Jaquith
JM, Duarte-García A, Matteson EL, Weyand CM and Warrington KJ:
Baricitinib for relapsing giant cell arteritis: A prospective
open-label 52-week pilot study. Ann Rheum Dis. 81:861–867.
2022.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Marsman DE, den Broeder N, van den Hoogen
FHJ, den Broeder AA and van der Maas A: Efficacy of rituximab in
patients with polymyalgia rheumatica: A double-blind, randomised,
placebo-controlled, proof-of-concept trial. Lancet Rheumatol.
3:E758–E766. 2011.
|
|
102
|
Bolhuis T: 1-year results of treatment
with rituximab in polymyalgia rheumatica: an extension study of a
randomised double-blind placebo-controlled trial. Lancet
Rheumathol. 5:e208–e214. 2023.
|
|
103
|
Dasgupta B, Unizony S, Warrington KJ,
Lazar JS, Giannelou A, Nivens C, Akinlade B, Wong W, Lin Y,
Buttgereit F, et al: LB0006 SARILUMAB in patients with relapsing
polymyalgia rheumatica: A phase 3, multicenter, randomized, double
blind, placebo controlled trial (SAPHYR). Ann Rheumatic Diseases.
81:210–211. 2022.
|
|
104
|
Castañeda S, García-Castañeda N,
Prieto-Peña D, Martínez-Quintanilla D, Vicente EF, Blanco R and
González-Gay MA: Treatment of polymyalgia rheumatica. Biochem
Pharmacol. 165:221–229. 2019.PubMed/NCBI View Article : Google Scholar
|
